645 related articles for article (PubMed ID: 16580440)
1. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
[TBL] [Abstract][Full Text] [Related]
2. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.
Lee PC; Port JL; Korst RJ; Liss Y; Meherally DN; Altorki NK
Ann Thorac Surg; 2007 Jul; 84(1):177-81. PubMed ID: 17588407
[TBL] [Abstract][Full Text] [Related]
4. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy.
Lee JD; Ginsberg RJ
Ann Thorac Surg; 1996 Aug; 62(2):338-41. PubMed ID: 8694587
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with true pathologic stage I non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
[TBL] [Abstract][Full Text] [Related]
7. Cost-efficacy of endoscopic ultrasonography with fine-needle aspiration vs. mediastinotomy in patients with lung cancer and suspected mediastinal adenopathy.
Aabakken L; Silvestri GA; Hawes R; Reed CE; Marsi V; Hoffman B
Endoscopy; 1999 Nov; 31(9):707-11. PubMed ID: 10604611
[TBL] [Abstract][Full Text] [Related]
8. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.
Cerfolio RJ; Bryant AS; Ojha B
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150
[TBL] [Abstract][Full Text] [Related]
9. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA;
Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
[TBL] [Abstract][Full Text] [Related]
10. Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis.
Ferguson MK
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1935-42. PubMed ID: 14688709
[TBL] [Abstract][Full Text] [Related]
11. [Clinical value of cervical mediastinoscopy in non-small cell lung cancer of stage I].
Zhang SY; Wang X; Zhu ZH; Zeng CG; Rong TH; Zheng L; Fu JH; Xie ZM; Zhang X; Yu H
Ai Zheng; 2005 Mar; 24(3):349-52. PubMed ID: 15757540
[TBL] [Abstract][Full Text] [Related]
12. The validity of preoperative lymph node staging guidelines of European Society of Thoracic Surgeons in non-small-cell lung cancer patients.
Gunluoglu MZ; Melek H; Medetoglu B; Demir A; Kara HV; Dincer SI
Eur J Cardiothorac Surg; 2011 Aug; 40(2):287-90. PubMed ID: 21185733
[TBL] [Abstract][Full Text] [Related]
13. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.
von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM
J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730
[TBL] [Abstract][Full Text] [Related]
14. Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients.
Iskender I; Kapicibasi HO; Kadioglu SZ; Sevilgen G; Tezel C; Kosar' A; Atasalihi A; Kir A
Acta Chir Belg; 2012; 112(3):219-25. PubMed ID: 22808763
[TBL] [Abstract][Full Text] [Related]
15. The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis.
Søgaard R; Fischer BM; Mortensen J; Rasmussen TR; Lassen U
Value Health; 2013; 16(1):57-65. PubMed ID: 23337216
[TBL] [Abstract][Full Text] [Related]
16. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.
De Leyn P; Lardinois D; Van Schil PE; Rami-Porta R; Passlick B; Zielinski M; Waller DA; Lerut T; Weder W
Eur J Cardiothorac Surg; 2007 Jul; 32(1):1-8. PubMed ID: 17448671
[TBL] [Abstract][Full Text] [Related]
17. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
18. Is routine mediastinoscopy indicated for patients with T1 non-small cell lung cancer?
Dincer SI; Demir A; Akin H; Gunluoglu MZ; Metin M; Melek H; Gurses A
Indian J Chest Dis Allied Sci; 2006; 48(4):249-52. PubMed ID: 16970289
[TBL] [Abstract][Full Text] [Related]
19. Mediastinal staging of lung cancer. Is mediastinoscopy still essential?
Kristensen S; Aaby C; Nielsen SM
Dan Med Bull; 1995 Apr; 42(2):192-4. PubMed ID: 7664577
[TBL] [Abstract][Full Text] [Related]
20. Accessing the aortopulmonary window (#5) and the paraaortic (#6) lymph nodes in patients with non-small cell lung cancer.
Cerfolio RJ; Bryant AS; Eloubeidi MA
Ann Thorac Surg; 2007 Sep; 84(3):940-5. PubMed ID: 17720403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
